Healthway Medical (5NG.SG) +9.7% at 2-month high of $0.17 on robust volume. Traders attribute the gains to expectations the company may unveil new major shareholders after Reuters reported a senior executive saying Healthway is speaking to unnamed potential investors.
Posts Tagged ‘healthway’
Healthway up on talks with potential investors
December 13th, 2010 |
No Comments
Shares of Singapore’s Healthway Medical (HEMC.SI) jumped 9.7% on Monday to an eight-week high after Reuters reported the firm was in talks with potential investors keen on taking a stake in the firm, traders said.
Healthway Medical Corp may get new outside investors
December 10th, 2010 |
No Comments
Healthway Medical Corp <HEMC.SI>, which runs medical and dental clinics in Singapore and China, is speaking to potential investors who have expressed an interest in taking a stake, a company executive said.
“Healthcare in Singapore has become a very attractive sector for investors and Healthway has had its share of interest,” Adrian Leong, group medical director and managing director of medical services, told Reuters in an interview.
Healthway Medical Group – Corporate moves
December 2nd, 2010 |
No Comments
Lam Pin Woon has been appointed ED wef Jan 1, 2011
Work experience: CEO, Health Promotion Board; CEO (group health supplements division), Cerebos Pacific Ltd
Healthway Medical started at Inline by StanChart
September 16th, 2010 |
No Comments
Standard Chartered starts Healthway Medical (5NG.SG) at Inline with $0.20 target price, based on discounted cashflow valuation, implying 36x 2010 P/E, according to Dow Jones.
Stanchart says healthcare group’s aggressive expansion, via opening chain of clinics in China, setting up specialist center in Singapore, has significant long-term potential, but notes company faces challenges in execution.
Healthway Medical Corp – Corporate moves
August 25th, 2010 |
No Comments
Dr Adrian Francis Leong Peng Kheong has been appointed MD/medical director, medical services wef Aug 1
Work experience: Adjust Professor, Dept of Surgery, Yong Loo Lin School of Medicine, National University of Singapore
Healthway Medical rated ‘buy’ by DMG
August 24th, 2010 |
No Comments
DMG & Partners Securities in an Aug 24 research report says: “Healthway recorded a dismal 2Q10 net profit ($0.1m, -97.2% y-o-y), dragged down by start-up costs of its new medical centres and lower-than-expected patient load of its new specialists.
Healthway Medical target cut to $0.23 by DMG
August 23rd, 2010 |
No Comments
DMG cuts Healthway Medical (5NG.SG) target price to $0.23 from $0.30 after slashing FY10 earnings estimate to $4.7 million from $16.0 million to reflect weak 2Q10 results, higher-than-expected start-up costs, says Dow Jones.
DMG notes healthcare group actively expanding in China, with plans to operate 20 medical centres there by year end after recently securing contracts to manage 12. Keeps Buy call.
Healthway Medical +8.8% on China property move
August 19th, 2010 |
No Comments
Healthway Medical Group (5NG.SG) +8.8% at $0.185 in active trade as company’s planned diversification into property development in China fuels hopes for additional income streams, according to Dow Jones.
The proposal, subject to shareholders’ approval, involves building medical facilities including hospitals, retirement homes, mixed developments comprising medical facilities and serviced apartments or hotels.
Healthway Medical +2.6%; Outlook favourable, says DMG
June 25th, 2010 |
No Comments
Healthway Medical (5NG.SG) +2.6% at $0.195 in active trade, holding near 52-week high of $0.21 set last week, says Dow Jones.
Interest in past weeks driven by substantial shareholder Peter Lim increasing his stake to 7.21% via series of open market purchases. On fundamentals, DMG, which has Buy call with $0.30 target, says outlook for healthcare group favourable as it continues to make inroads in China using proceeds from placement of shares to World Bank’s International Finance Corp, other investors carried out earlier this year.
Healthway Medical posts 1Q net profit of $1.4m, down 64%
May 14th, 2010 |
No Comments
Healthway Medical Corp, the operator of private medical centres and clinics, says net profit attributable to shareholders fell 63.9% to $1.4 million the quarter ended 31 March 2010 (1QFY2010) from $3.8 million in 1QFY2009. Revenue fell 6.3% to $22.2 million from $23.7 million.
Healthway well placed to ride recovery, says DMG
March 17th, 2010 |
No Comments
Healthway Medical (5NG.SG) is trading at 17 cents as investors bet company’s expansion plans leave it well placed to benefit from growing demand for private healthcare across region; resistance tipped at Monday’s high of 18.5 cents, reported Dow Jones Newswires.
Healthway Medical setting up Healthway Specialist Centre at TripleOne Somerset
March 16th, 2010 |
No Comments
Healthway Medical Corporation says it is setting up Healthway Specialist Centre at TripleOne Somerset which will be fully completed in several phases over a period of three years.
Upon completion of the Healthway Specialist Centre Project, the centre would occupy up to 150,000 square feet and 7 floors of TripleOne Somerset. The total investment cost of the centre is estimated to be $40 million. The first phase of project on Level 2 of TripleOne Somerset will be completed in late March 2010. This is expected to cost $2 million.
March 16: SIA Engineering, SIA, Cosco, Healthway Medical, Chip Eng Seng, Novo Group
March 16th, 2010 |
No Comments
Singapore’s benchmark Straits Times Index (.FTSTI) slipped 0.24% to 2,874.33 points yesterday. US stocks were little changed last night as a late rebound in financial stocks offset nagging worries the Chinese government may tighten credit, a move that could slow growth in the global economy. Here are some stocks and factors to watch:
Healthway places out 108m new shares to International Finance Corp
March 15th, 2010 |
No Comments
Healthway Medical Corporation says the company has agreed to place out 108 million new shares to International Finance Corporation (IFC), a member of the World Bank Group, at 13 cents per share.
This equity investment is part of the US$25 million ($35 million) financing package from IFC, which comprises a US$15 million senior loan and equity of US$10 million, to fund the group’s expansion plans in China.
Healthway Medical’s target price raised to 26 cents
March 8th, 2010 |
No Comments
DMG has raised Healthway Medical’s (5NG.SG) target price to 26 cents from 21 cents to factor in growth from new clinics, maintaining a “buy” rating.
The house is positive on the healthcare services company’s plans to ramp up China footprint, while keeping its Singapore expansion plans intact.
Healthway Medical plans to raise $46m in equity, debt for China expansion
January 27th, 2010 |
No Comments
Healthway Medical Corp says it plans to raise $46.2 million by a private placement and loan package with International Finance Corporation (IFC) and another private placement with One Organisation and its directors.
Healthway Medical says IFC, a member of the World Bank Group, has agreed to subscribe for up to 108 million new shares at 13 cents each, raising $14 million.
IFC will also extend a long-term loan, for a period of up to 10 years, of US$15 million ($21 million) to Healthway Medical.
Singapore’s Healthway seeks China growth
January 19th, 2010 |
No Comments
Singapore medical services firm Healthway Medical (HEMC.SI) said China would account for half of its revenue by 2015 from an estimated 5% this year as it seeks aggressive growth in the world’s third-largest economy.
Healthway plans to open 40–50 new medical centres in China over the next five years including six in Shanghai this year, the firm’s managing director Wong Weng Hong told Reuters in an interview today.